KRISTIE ZACHARIAH: Open Payments
NPI 1295373538 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 48 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $515 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $153 |
| Novo Nordisk Inc | 9 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $141 |
| PFIZER INC. | 6 | $112 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| ABBVIE INC. | 4 | $83 |
| Dexcom, Inc. | 2 | $45 |
| Exact Sciences Corporation | 2 | $32 |
| Astellas Pharma US Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: JARDIANCE, MOUNJARO, PAXLOVID, QULIPTA, Wegovy, TRELEGY ELLIPTA, Dexcom G6 Transmitter, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
